Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan;55(1):23-36.
doi: 10.1002/jmri.27361. Epub 2020 Sep 17.

VI-RADS for Bladder Cancer: Current Applications and Future Developments

Valeria Panebianco  1 , Martina Pecoraro  1 , Francesco Del Giudice  2 , Mitsuru Takeuchi  3 , Valdair F Muglia  4 , Emanuele Messina  1 , Stefano Cipollari  1 , Gianluca Giannarini  5 , Carlo Catalano  1 , Yoshifumi Narumi  6
Affiliations
Review

VI-RADS for Bladder Cancer: Current Applications and Future Developments

Valeria Panebianco et al. J Magn Reson Imaging. 2022 Jan.

Abstract

Bladder cancer (BCa) is among the ten most frequent cancers globally. It is the tumor with the highest lifetime treatment-associated costs, and among the tumors with the heaviest impacts on postoperative quality of life. The purpose of this article is to review the current applications and future perspectives of the Vesical Imaging Reporting and Data System (VI-RADS). VI-RADS is a newly developed scoring system aimed at standardization of MRI acquisition, interpretation, and reporting for BCa. An insight will be given on the BCa natural history, current MRI applications for local BCa staging with assessment of muscle invasiveness, and clinical implications of the score for disease management. Future applications include risk stratification of nonmuscle invasive BCa, surveillance, and prediction and monitoring of therapy response. LEVEL OF EVIDENCE: 3 TECHNICAL EFFICACY STAGE: 2.

Keywords: VI-RADS score; bladder neoplasms; magnetic resonance imaging; staging.

PubMed Disclaimer

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394-424.
    1. Richters A, Aben KKH, Kiemeney LAML. The global burden of urinary bladder cancer: An update. World J Urol 2020;38:1895-1904.
    1. van Osch FH, Jochems SH, van Schooten F-J, Bryan RT, Zeegers MP. Quantified relations between exposure to tobacco smoking and bladder cancer risk: A meta-analysis of 89 observational studies. Int J Epidemiol 2016;45(3):857-870.
    1. Cassell A, Yunusa B, Jalloh M, et al. Non-muscle invasive bladder cancer: A review of the current trend in Africa. World J Oncol 2019;10(3):123-131.
    1. Al-Husseini MJ, Kunbaz A, Saad AM, et al. Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: A SEER-based analysis. BMC Cancer 2019;19(1):46.